Close Menu

Clinical Trial Rep

Job Location
6392 Via Real
Carpinteria, CA 93013
United States
Job Description

Agilent inspires and supports discoveries that advance the quality of life. We provide life science, diagnostic and applied market laboratories worldwide with instruments, services, consumables, applications and expertise. Agilent enables customers to gain the answers and insights they seek ---- so they can do what they do best: improve the world around us. Information about Agilent is available at

Responsible for overall clinical study management, including planning, communication, coordination and practical tasks for the studies. Coordinates Ethical Committee and Institutional Review Board notifications. Builds, maintains and coordinates study files and archiving. Supporting testing laboratories including selection of laboratories for the studies. Partners alongside Clinical Research Organizations and ensures monitoring of studies, data collection and handling. Prepares, revises and maintains procedures for the conduct of studies.

  • Works on clinical assignments with broadly defined objectives
  • Solves straight-forward issues, challenges and problems within field of specialization

 This is an on-site position 

  • Bachelors or Masters Degree or University Degree or equivalent
  • Bachelors or Masters Degree in a Science or Medical-related field or RN preferred
  • 2+ year demonstrated experience
  • Ability to travel 30-50% of the time
  • Strong written and verbal communication skills
  • CDx experience desired

A new report finds that women, especially women of color, are missing among the high-earners at research universities in the US, the Chronicle of Higher Education writes. 

Researcher-parents, especially mothers of small children, have lost research time during the COVID-19 pandemic, according to the Chronicle of Higher Education.

Inside Higher Ed reports that the preprint site medRxiv has taken off with the COVID-19 pandemic.

Inside Higher Ed reports some university professors are pushing back against plans for increased numbers of in-person classes for next semester.